Literature DB >> 3807562

[Breast-saving therapy--a safe alternative in primary treatment of breast cancer?].

H F Rauschecker.   

Abstract

Since Fisher's publication in March 1985 conservative breast cancer treatment is viewed ever more uncritically. In order to avoid local recurrence this therapeutic modality can only be justified in connection with radiotherapy the negative effects of which are often neglected. Thoroughly competent surgical technique, careful pathological work-up of the tumor material and a computerized radiation planning as a prerequisite for a homogeneous radiotherapy of the breast are necessary to perform conservative breast cancer therapy. Legal-ethical aspects make it imperative to inform the patient about the advantages and disadvantages of conservative versus radical therapy. The realization of conservative breast cancer treatment on a broad basis is, at present, only justifiable under study conditions.

Entities:  

Mesh:

Year:  1986        PMID: 3807562     DOI: 10.1007/bf01274406

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  4 in total

1.  Decreased survival related to irradiation postoperatively in early operable breast cancer.

Authors:  J Stjernswärd
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

2.  [Conservative treatment of breast cancer].

Authors:  U Veronesi
Journal:  Chirurg       Date:  1985-04       Impact factor: 0.955

3.  Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population.

Authors:  S Rotstein; H Blomgren; B Petrini; J Wasserman; E Baral
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-05       Impact factor: 7.038

4.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

Authors:  B Fisher; M Bauer; R Margolese; R Poisson; Y Pilch; C Redmond; E Fisher; N Wolmark; M Deutsch; E Montague
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.